HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

calaspargase pegol

used to treat acute lymphoblastic leukemia

Also Known As:

Asparlas; SC-PEG asparaginase; calaspargase pegol-mknl

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Athale, Uma H: 1 article (11/2021)
2.	Blonquist, Traci M: 1 article (11/2021)
3.	Clavell, Luis A: 1 article (11/2021)
4.	Cole, Peter D: 1 article (11/2021)
5.	Cronholm, Sarah M: 1 article (11/2021)
6.	Harris, Marian H: 1 article (11/2021)
7.	Hunt, Sarah K: 1 article (11/2021)
8.	Kay-Green, Samantha: 1 article (11/2021)
9.	Kelly, Kara M: 1 article (11/2021)
10.	Koch, Victoria: 1 article (11/2021)

Related Diseases

1.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/01/2020 - "In December 2018, the FDA approved calaspargase pegol-mknl (Asperlas, Servier Pharmaceuticals) for acute lymphoblastic leukemia (ALL) in children and young adults up to age 21. " 01/01/2020 - "FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults." 12/01/2014 - "Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4." 11/01/2021 - "Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001." 11/01/2021 - "Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia (ALL) Consortium Protocol 11-001 assessed efficacy and toxicity of calaspargase pegol (calaspargase), a novel pegylated asparaginase formulation with longer half-life, compared with the standard formulation pegaspargase. "
2.	Neoplasms (Cancer) 11/01/2021 - "Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia (ALL) Consortium Protocol 11-001 assessed efficacy and toxicity of calaspargase pegol (calaspargase), a novel pegylated asparaginase formulation with longer half-life, compared with the standard formulation pegaspargase. "

Related Drugs and Biologics

1.	Asparaginase (Elspar)
2.	Enzymes
3.	Asparagine
4.	pegaspargase (Oncaspar)